The primary objectives of this study are:- Can EEnG measure colonic motility/activity?- Can EEnG be used to distinguish between healthy subjects and patients suffering from a colonic motility disorder.Secundary objective:- What is theā¦
ID
Source
Brief title
Condition
- Gastrointestinal motility and defaecation conditions
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary study parameter is the relative power increase (pre-prandial vs.
post-prandial) of the EEnG signal (in mV/Hz^2) in the relevance frequency
region for colonic motility. This power increase can then be compared between
healthy subjects and patients to investigate whether colonic motility can be
measured using EEnG and also whether EEnG could be used as diagnostic tool for
colonic motility disorders.
Secondary outcome
The questionnaires are summarized in a grand total score, which can be used to
compare the burden of the EEnG procedure with the Gold Standard procedures.
Background summary
Bowel problems are encountered in a large part of the population, ranging from
babies and children to adults. To treat these patients adequately, it is
important that the right diagnose is made. This, however, is easier said than
done, especially for motility disorders. These disorders are often
misunderstood, and the process to diagnosis is often long and is filled with
diagnostics that are burdensome, painful and/or sometimes even unnecessary. To
improve this process, we aim to investigate if Electro-Entero-Graphy (EEnG),
where surface electrodes are positioned on the abdomen to measure electrical
activity originating in the colon, could be used as a new, non-invasive
diagnostic tool in the diagnosis of patients suffering from colonic motility
disorders.
Study objective
The primary objectives of this study are:
- Can EEnG measure colonic motility/activity?
- Can EEnG be used to distinguish between healthy subjects and patients
suffering from a colonic motility disorder.
Secundary objective:
- What is the reproducibility of the EEnG measurements in healthy adults?
- How is the patient experienced burden of the EEnG procedure relative to the
patient experienced burden of the Gold Standard diagnostic method by which the
colonic motility disorders have been diagnosed.
Study design
This study is an intervention study in which the measurement outcomes of
healthy controls are compared to those of patients.
Intervention
All participants are asked to fast at least 4 hours (3 hours for babies < 1
years old) before the start of the EEnG procedure.
At the start of the EEnG procedure, the electrodes are positioned on the
abdomen (under ultrasound guidance) and the participants are asked to lay still
for 20 minutes.
Next, they have to eat a standardized meal (in advance composed together with
them), after which they have to lay still for another 20 minutes.
At the end, they are asked to complete a questionnaire regarding the burden
they experienced from the procedure.
Patients who are already diagnosed with a colonic motility disorder are also
asked to fill out a questionnaire regarding the burden of the Gold Standard
diagnostic they are diagnosed with.
Patients getting the Gold Standard diagnostic method in the near future will
fill out this questionnaire afterwards.
Study burden and risks
The burden will mainly consist of the duration of the procedure (around 1.5
hours for children and patients, around 3 hours in total for healthy adults)
and can be a little boring (laying still for 20 minutes for two times). There
are no risks associated with participation: the used devices (ultrasound and
electrodes + amplifier) are approved for medical use and do not pose any risk.
The importance of examining EEnG als diagnostic tool in babies and children in
this study is fourfold:
- motility disorders comprise 3-5% of the consultations of paediatricians;
- the current diagnostic process often involves anesthesia, which negatively
influences brain development in young children;
- the current uncertain waiting time and invasive diagnostics pose a great
burden to the parents;
- only babies and children can present with untreated Hirschsprung*s disease,
which is the ultimate colonic motility disorder to evaluate the potential of
EEnG to diagnose colonic motility disorders. In Hirschsprung's disease, the
nerves controlling colonic motility are absent in (a part of) the colon, which
means that if EEnG could be used as diagnostic tool, this should be the case in
patients suffering from Hirschsprung's disease.
Geert Grooteplein Zuid 10
Nijmegen 6525 GA
NL
Geert Grooteplein Zuid 10
Nijmegen 6525 GA
NL
Listed location countries
Age
Inclusion criteria
All subjects: babies/children < 12 years and adults > 18 years.
For patients < 12 years:
o suffering from surgically untreated HSCR as determined by a rectal biopsy, or
o suspected of HSCR, for which a rectal biopsy is planned
o suffering from a surgically untreated colonic motility disorder as
previously diagnosed.
For adult patients:
o Suffering from a (suspected,) surgically untreated functional colonic
motility disorder (such as slow-transit constipation, idiopathic/therapy
resistant constipation), as diagnosed previously or will be diagnosed in the
near future using the gold standard method.
Exclusion criteria
All subjects:
- For adults: BMI > 27 kg/m2
- For babies/children: weight for length > 2.5 standard deviation of WHO Child
Growth Standard
- Pregnancy
- Diabetes
- Any food intolerance
- Intestinal stoma
- Continuous tube feeding
Healthy controls:
- Any known gastro-intestinal disorders
- Use of laxatives in the past two years
Patients:
- (partially) resected small intestines and/or colon
- inflammatory bowel diseases
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
ClinicalTrials.gov | NCT04624334 |
CCMO | NL75302.091.20 |